Submit your email to push it up the queue
Ebos Group Limited, commonly referred to as Ebos, is a leading healthcare and pharmaceutical company headquartered in Australia. Established in 1922, Ebos has grown to become a prominent player in the industry, with significant operations across New Zealand and Australia. The company focuses on the distribution of medical supplies, pharmaceuticals, and healthcare products, catering to hospitals, pharmacies, and aged care facilities. Ebos is renowned for its extensive product range, which includes medical consumables, surgical instruments, and pharmacy services, all distinguished by their quality and reliability. With a strong market position, Ebos has achieved notable milestones, including strategic acquisitions that have expanded its reach and capabilities. As a trusted partner in the healthcare sector, Ebos continues to innovate and adapt, ensuring it meets the evolving needs of its customers.
How does Ebos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ebos's score of 20 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, EBOS Group Limited reported total carbon emissions of approximately 3,530,000 kg CO2e for Scope 1 and 18,289,000 kg CO2e for Scope 2 globally. In Australia, the company recorded Scope 1 emissions of about 2,796,000 kg CO2e and Scope 2 emissions of the same amount, indicating a significant reliance on purchased electricity. In New Zealand, Scope 1 emissions were approximately 670,000 kg CO2e, with Scope 2 emissions at about 715,000 kg CO2e. For 2023, EBOS's emissions included approximately 2,984,000 kg CO2e for Scope 1 and 16,993,000 kg CO2e for Scope 2 globally, while in Australia, Scope 1 emissions were about 2,680,000 kg CO2e, with Scope 2 emissions reaching approximately 16,153,000 kg CO2e. In New Zealand, Scope 1 emissions were around 304,000 kg CO2e, and Scope 2 emissions were about 840,000 kg CO2e. EBOS has not disclosed any specific reduction targets or initiatives as part of its climate commitments, nor does it appear to have cascaded data from a parent organization. The company is actively engaged in monitoring its emissions but has not set formal targets through initiatives such as the Science Based Targets initiative (SBTi). Overall, EBOS Group Limited's emissions data reflects a substantial carbon footprint, particularly from electricity consumption, highlighting the need for strategic climate action moving forward.
Access structured emissions data, company-specific emission factors, and source documents
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Scope 1 | - | 000,000 | 0,000,000 | 0,000,000 |
Scope 2 | 12,556,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ebos is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.